Five infants could not be unequivocally assigned to any group (concurrent administration/recent switch from low- to high-CML-containing formula, consumption of formula not analyzed for CML content). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.